SCHEMBL17732272

SCHEMBL17732272

CCOC(=O)c1cn2c(cc1=O)-c1cc(OCC)c(OCC)cc1CC2CN1Oc2ccccc2O1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
TP53 P04637 3/20 0.39
ACHE P22303 1/20 0.36
GAA P10253 2/20 0.34
NPC1 O15118 1/20 0.34
MAPK1 P28482 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 4/20 0.33
LMNA P02545 3/20 0.33
MEN1 O00255 2/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
USP2 O75604 1/20 0.33
HPGD P15428 1/20 0.33
TNNI3 P19429 1/20 0.33
CASP1 P29466 1/20 0.33
BRCA1 P38398 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17709356 0.86 KMT2A (0.42) MAPTTP53ACHEGAANPC1
SCHEMBL16930262 0.84 ACHE (0.43) MAPTTP53ACHEGAANPC1
SCHEMBL17709408 0.83 ACHE (0.39) MAPTTP53ACHEGAANPC1
SCHEMBL17709283 0.82 ACHE (0.42) MAPTTP53ACHEGAANPC1
SCHEMBL17709336 0.81 ACHE (0.40) MAPTTP53ACHEGAANPC1
SCHEMBL16929890 0.81 KDM4E (0.45) ACHEGAAKMT2ALMNAKDM4E
SCHEMBL17709292 0.80 TP53 (0.42) MAPTTP53ACHEKMT2ALMNA
SCHEMBL17709291 0.79 ACHE (0.39) MAPTTP53ACHEGAANPC1
SCHEMBL16930255 0.79 ACHE (0.47) MAPTTP53ACHEGAANPC1
SCHEMBL21280070 0.78 ACHE (0.38) MAPTTP53ACHEGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3215504-A1 NOVEL 6,7-DIHYDROBENZO[A]QUINOLIZIN-2-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2017-09-13 EP disclosed
WO-2016071215-A1 NOVEL 6,7-DIHYDROBENZO[A]QUINOLIZIN-2-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. HOFFMANN-LA ROCHE AG (CH) 2016-05-12 WO disclosed